hydroxyproline has been researched along with 5-(4-methoxybenzylidene)thiazolidine-2,4-dione in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Chen, Z; Luo, Y; Ma, L; Ma, Y; Qi, B; Wang, G; Wei, X; Wei, Y; Zheng, H | 1 |
1 other study(ies) available for hydroxyproline and 5-(4-methoxybenzylidene)thiazolidine-2,4-dione
| Article | Year |
|---|---|
(Z)-5-(4-Methoxybenzylidene)thiazolidine-2,4-dione, a novel readily available and orally active glitazone, attenuates the bleomycin-induced pulmonary fibrosis in vivo.
Topics: Animals; Bleomycin; Bronchoalveolar Lavage Fluid; Cell Line; Collagen; Cytokines; Dose-Response Relationship, Drug; Hydroxyproline; Lung; Lymphocytes; Macrophages; Mice; Neutrophils; Pulmonary Fibrosis; Smad3 Protein; Thiazolidinediones; Transforming Growth Factor beta1 | 2011 |